Boston Scientific (BSX) closed the latest trading day at $93.67, indicating a +1.11% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 1.81%. At ...

Boston Scientific Corp. closed 12.60% below its 52-week high of $107.17, which the company achieved on February 5th.

Elixir trails J&J’s Shockwave but has outpaced Bolt Medical to the European market with its mechanical IVL system.

Truist lowered the firm’s price target on Boston Scientific (BSX) to $113 from $120 and keeps a Buy rating on the shares as part of a broad ...

Boston Scientific BSX shares rallied 6.8% in the last trading session to close at $96.77. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...

Boston Scientific Corp.’s up to $664 million acquisition of Bolt Medical Inc. closed just days after Bolt secured U.S. FDA 520(k) clearance for its intravascular lithotripsy (IVL) system, positioning ...

The device is differentiated from other Shockwave products, and rival catheters from Abbott and Boston Scientific, because it ...